Cargando…

Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab

BACKGROUND: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare and aggressive tumor with a poor prognosis and standard therapy has not yet been established. CASE: A 65‐year‐old male with a cough for 2 months presented to our hospital. He was clinically diagnosed with non small cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadota, Naoki, Hatakeyama, Nobuo, Hino, Hiroyuki, Kunishige, Michihiro, Kondo, Yoshihiro, Okano, Yoshio, Machida, Hisanori, Naruse, Keishi, Shinohara, Tsutomu, Sakiyama, Shoji, Ogushi, Fumitaka, Takeuchi, Eiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351647/ https://www.ncbi.nlm.nih.gov/pubmed/34817132 http://dx.doi.org/10.1002/cnr2.1589

Ejemplares similares

A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer
por: Kondo, Yoshihiro, et al.
Publicado: (2022)

Late‐onset acute type 1 diabetes mellitus 7 months after discontinuation of pembrolizumab against lung cancer
por: Ichihara, Seiya, et al.
Publicado: (2022)

Dramatic response to immunochemotherapy followed by salvage surgery in an elderly lung cancer patient
por: Okano, Yoshio, et al.
Publicado: (2021)

Non‐small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib
por: Kunishige, Michihiro, et al.
Publicado: (2022)

Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
por: Takeuchi, Eiji, et al.
Publicado: (2022)

Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors
por: Takeuchi, Eiji, et al.
Publicado: (2023)

Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion
por: Takeuchi, Eiji, et al.
Publicado: (2021)

Elevated Levels of Intelectin-1, a Pathogen-binding Lectin, in the BAL Fluid of Patients with Chronic Eosinophilic Pneumonia and Hypersensitivity Pneumonitis
por: Shinohara, Tsutomu, et al.
Publicado: (2018)

Kikuchi-Fujimoto disease associated with community acquired pneumonia showing intrathoratic lymphadenopathy without cervical lesions
por: Naito, Nobuhito, et al.
Publicado: (2015)

Improvement in idiopathic nonspecific interstitial pneumonia after smoking cessation
por: Shinohara, Tsutomu, et al.
Publicado: (2014)

BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6
por: Tobiume, Makoto, et al.
Publicado: (2014)

Type A thymoma: a rare cause of neoplastic cardiac tamponade with long-term survival
por: Takashima, Mika, et al.
Publicado: (2022)

Solitary costal plasmacytoma mimicking lung cancer metastasis
por: Kadota, Naoki, et al.
Publicado: (2017)

Cavitary lung cancer with cartilage tissues in the wall mimicking aspergilloma
por: Taoka, Takashige, et al.
Publicado: (2017)

Massive eosinophilia despite severe aplastic anemia
por: Takahashi, Aya, et al.
Publicado: (2022)

Bronchopleural fistula following M. abscessus infection 11 years after lobectomy for lung cancer
por: Inayama, Mami, et al.
Publicado: (2013)

Asymptomatic tracheal MALT lymphoma discovered on spirometric findings presenting with elevated respiratory resistance
por: Kadota, Naoki, et al.
Publicado: (2015)

Diffuse (18)F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma
por: Harada, Shu, et al.
Publicado: (2016)

Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma
por: Shinohara, Tsutomu, et al.
Publicado: (2013)

Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report
por: Okano, Yoshio, et al.
Publicado: (2016)

Mycobacterium abscessus ssp. abscessus infection progressing to empyema from vertebral osteomyelitis in an immunocompetent patient without pulmonary disease: a case report
por: Kadota, Naoki, et al.
Publicado: (2019)

Positron Emission Tomography/Computed Tomography Findings of Granulocyte Colony-stimulating Factor-producing Lung Cancer
por: Okano, Yoshio, et al.
Publicado: (2021)

Mycobacterium Shinjukuense Pulmonary Disease Progressed to Pleuritis after Iatrogenic Pneumothorax: A Case Report
por: Taoka, Takashige, et al.
Publicado: (2020)

Disseminated tuberculosis after pregnancy progressed to paradoxical response to the treatment: report of two cases
por: Shinohara, Tsutomu, et al.
Publicado: (2016)

Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations
por: Kunishige, Michihiro, et al.
Publicado: (2023)

Evaluation of the Trend of Deformation around the Kanto Region Estimated Using the Time Series of PALSAR-2 Data †
por: Nonaka, Takashi, et al.
Publicado: (2020)

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
por: Cyriac, Sanju, et al.
Publicado: (2021)

Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma
por: Senda, Masaya, et al.
Publicado: (2023)

Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report
por: Kamei, Maiko, et al.
Publicado: (2015)

Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report
por: Lepir, Tanja, et al.
Publicado: (2019)

Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer
por: Chan, John K., et al.
Publicado: (2020)

Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
por: Gorshein, Elan, et al.
Publicado: (2021)

Pembrolizumab-Induced Vitiligo in Esophageal Squamous Cell Carcinoma Patient With Durable Complete Response
por: Wilkins, Matthew C, et al.
Publicado: (2021)

A rare anomaly of A4+5 on three-dimension multidetector computed tomography in lung cancer: A case report
por: Sakamoto, Shinichi, et al.
Publicado: (2019)

PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab
por: George, Saby, et al.
Publicado: (2018)

Single pembrolizumab treatment causing profound durable response in a patient with pulmonary pleomorphic carcinoma
por: Tokuyasu, Hirokazu, et al.
Publicado: (2019)

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer
por: Poma, Anello Marcello, et al.
Publicado: (2021)

A complete durable response of vaginal clear cell carcinoma with pembrolizumab: A case report
por: Porragas-Paseiro, Hector S., et al.
Publicado: (2023)

Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report
por: Nguyen, Olav Toai Duc, et al.
Publicado: (2020)

Rhabdomyolysis following single administration of pembrolizumab: Is severe immune-reaction a marker for durable treatment response?
por: Khetan, Varun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qcj0jde8rfcr2gktpjlgfsa3vu